JP2009527479A5 - - Google Patents

Download PDF

Info

Publication number
JP2009527479A5
JP2009527479A5 JP2008555401A JP2008555401A JP2009527479A5 JP 2009527479 A5 JP2009527479 A5 JP 2009527479A5 JP 2008555401 A JP2008555401 A JP 2008555401A JP 2008555401 A JP2008555401 A JP 2008555401A JP 2009527479 A5 JP2009527479 A5 JP 2009527479A5
Authority
JP
Japan
Prior art keywords
alkyl
heterocycloalkyl
cycloalkyl
alkoxy
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008555401A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009527479A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/004247 external-priority patent/WO2007098086A2/en
Publication of JP2009527479A publication Critical patent/JP2009527479A/ja
Publication of JP2009527479A5 publication Critical patent/JP2009527479A5/ja
Pending legal-status Critical Current

Links

JP2008555401A 2006-02-17 2007-02-16 ヒドロキシピペリジン誘導体とその使用 Pending JP2009527479A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77497206P 2006-02-17 2006-02-17
PCT/US2007/004247 WO2007098086A2 (en) 2006-02-17 2007-02-16 Hydroxypiperidine derivatives and uses thereof

Publications (2)

Publication Number Publication Date
JP2009527479A JP2009527479A (ja) 2009-07-30
JP2009527479A5 true JP2009527479A5 (cg-RX-API-DMAC10.html) 2010-04-08

Family

ID=38437913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555401A Pending JP2009527479A (ja) 2006-02-17 2007-02-16 ヒドロキシピペリジン誘導体とその使用

Country Status (4)

Country Link
US (2) US20090036429A1 (cg-RX-API-DMAC10.html)
EP (1) EP1991233A4 (cg-RX-API-DMAC10.html)
JP (1) JP2009527479A (cg-RX-API-DMAC10.html)
WO (1) WO2007098086A2 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2627221T3 (es) 2006-12-28 2017-07-27 Rigel Pharmaceuticals, Inc. Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso
CA2685029A1 (en) * 2007-04-26 2008-11-06 Avalon Pharmaceuticals Multi-ring compounds and uses thereof
EP2231600B1 (en) 2007-11-16 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
EP2231666B1 (en) 2007-12-12 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
WO2009132136A1 (en) 2008-04-23 2009-10-29 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
HUE052110T2 (hu) 2010-07-29 2021-04-28 Rigel Pharmaceuticals Inc AMPK-t aktiváló heterociklusos vegyületek és alkalmazásuk
US20160214967A1 (en) * 2013-09-30 2016-07-28 The University Of Tokyo Activator of adiponectin receptor
WO2017007634A1 (en) * 2015-07-06 2017-01-12 The Board Of Regents Of The University Of Texas System Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
AU2017311691B2 (en) 2016-08-18 2021-12-02 Vidac Pharma Ltd. Piperazine derivatives, pharmaceutical compositions and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263438A (en) * 1977-09-13 1981-04-21 Pfizer Inc. 3-[2,4-(Disubstituted)-phenyl]azacycloalkanones as analgesics
DK0641320T3 (da) * 1991-04-17 2001-08-20 Upjohn Co Substituerede (S)-3-phenylpiperidinderivater, deres fremstilling og deres anvendelse som dopaminautoreceptorantagonister
US7772432B2 (en) * 1991-09-19 2010-08-10 Astrazeneca Ab Amidobenzamide derivatives which are useful as cytokine inhibitors
US5519134A (en) * 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
GB9511694D0 (en) * 1995-06-09 1995-08-02 Fujisawa Pharmaceutical Co Benzamide derivatives
HRP970371A2 (en) * 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
TR200102911T2 (tr) * 1999-04-09 2002-01-21 Astrazeneca Ab Adamantan türevleri.
US7361666B2 (en) * 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
AU2003281632A1 (en) * 2002-07-24 2004-02-09 Eli Lilly And Company Dihydro-dibenzo(b,e)oxepine based selective estrogen receptor modulators, compositions and methods
US20060019256A1 (en) * 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7094791B2 (en) * 2003-07-31 2006-08-22 Avalon Pharmaceuticals, Inc. Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
SE0302488D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab New combination
AU2004273658A1 (en) * 2003-09-19 2005-03-31 Wisconsin Alumni Research Foundation (Warf) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist
CN1890208A (zh) * 2003-12-12 2007-01-03 伊莱利利公司 类鸦片受体拮抗剂
MX2007010076A (es) * 2005-02-17 2007-10-16 Astellas Pharma Inc Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo.

Similar Documents

Publication Publication Date Title
JP2010527915A5 (cg-RX-API-DMAC10.html)
RU2009106214A (ru) Ингибиторы ундекапренилпирофосфатсинтазы
CN102993148B (zh) 槲皮素衍生物或其类似物及其应用
JP2010509379A5 (cg-RX-API-DMAC10.html)
JP2004528376A5 (cg-RX-API-DMAC10.html)
CA2407149A1 (en) Melanin-concentrating hormone antagonist
JP2015096525A5 (cg-RX-API-DMAC10.html)
NZ532494A (en) Dibenzylamine compound and medicinal use thereof
RU2008141151A (ru) Производные n-гидроксилсульфонамида в качестве новых физиологически полезных доноров нитроксила
WO2008108386A1 (ja) 医薬組成物
JP2006521335A5 (cg-RX-API-DMAC10.html)
JP2002513793A5 (cg-RX-API-DMAC10.html)
ZA200507933B (en) Acetylene derivatives as inhibitors of histone deacetylase
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
CN103172612A (zh) 一种二苯并碘鎓盐及其抗癌应用
JP2007532627A5 (cg-RX-API-DMAC10.html)
CA2526989A1 (en) Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
JP2010535706A5 (cg-RX-API-DMAC10.html)
WO2007098086A2 (en) Hydroxypiperidine derivatives and uses thereof
BR112012029033A2 (pt) compostos
JP2013514384A5 (cg-RX-API-DMAC10.html)
MX2009010243A (es) Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
Hou et al. Synthesis and Structure‐Activity Relationships of A Novel Class of Dithiocarbamic Acid Esters as Anticancer Agent
CN103214422B (zh) 一类新型取代胺基咪唑酮衍生物的制备方法及抗癌作用
JP2006515854A5 (cg-RX-API-DMAC10.html)